Rocket Lab stock slides on possible $750M equity offering
Proactiveinvestors NA· 2025-09-16 16:17
About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...
Are rare sneakers and cars good investments? How you can build wealth with alternative assets
Yahoo Finance· 2025-09-16 16:17
Many investors consider it an asset reserved for the top 1%, but that’s no longer the case: Masterworks is making elite art investments accessible and hassle-free.Fine art is one investment that consistently outperforms the stock market over the long term, making it an increasingly popular tangible asset. Some contemporary art has even outperformed the S&P 500 over the past few decades, delivering an annual return of 11.5% from 1995 to 2023, compared to the S&P 500’s 9.6% during the same period.In spite of ...
Centrus Energy Corp. (LEU): A Bull Case Theory
Yahoo Finance· 2025-09-16 16:16
We came across a bullish thesis on Centrus Energy Corp. on Astute Investor’s Calculus’s Substack by Shailesh Kumar, MBA and James Foord. In this article, we will summarize the bulls’ thesis on LEU. Centrus Energy Corp.'s share was trading at $201.54 as of September 3rd. LEU’s trailing and forward P/E were 32.66 and 51.02, respectively according to Yahoo Finance. Centrus Energy (LEU) has emerged as a strategic linchpin in America’s nuclear revival, uniquely positioned as the only U.S.-listed company capab ...
Novo Nordisk A/S (NVO): A Bull Case Theory
Yahoo Finance· 2025-09-16 16:15
We came across a bullish thesis on Novo Nordisk A/S on Summit Stocks’s Substack by Summit Stocks. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S 's share was trading at $56.74 as of September 3rd. NVO’s trailing and forward P/E were 14.49 and 13.48 respectively according to Yahoo Finance. 5 Countries With The Highest Rate Of Diabetes During a double press release, Novo Nordisk delivered a double shock with a sales warning and the appointment of a new CEO, sending shares dow ...
Kimberly-Clark Leverages Innovation and Premiumization to Aid Growth
ZACKS· 2025-09-16 16:15
Key Takeaways Kimberly-Clark expands market share with innovation, consumer focus and product investments.New launches like Skin Essentials target both premium and value-conscious segments.The Powering Care strategy boosts growth with innovation, margin optimization and restructuring.Kimberly-Clark Corporation’s (KMB) focus on innovation, consumer-centric approach and strategic investments in product development have been strengthening its position and market share expansion. The company looks to bolster gr ...
INTC vs. AMD: Which AI-Driven Chip Stock Should You Bet on Now?
ZACKS· 2025-09-16 16:15
Key Takeaways Intel is expanding capacity and advancing AI with its Xeon 6 processors and CHIPS Act funding.Advanced Micro is boosting its AI edge with MI300 accelerators and 7 nm-based processors.AMD's 2025 sales are seen rising 26.9%, while Intel expects a 1.7% revenue decline.Intel Corporation (INTC) and Advanced Micro Devices, Inc. (AMD) are two premier semiconductor firms competing in the CPU market, with both focusing on AI (artificial intelligence) and advanced chip technologies. Intel, reportedly th ...
Will GSK Be Able to Resolve Its Vaccine Challenges Anytime Soon?
ZACKS· 2025-09-16 16:15
Key Takeaways GSK vaccine sales fell in the U.S. as Shingrix and Arexvy declined sharply in early 2025.Revised ACIP guidance narrowed Arexvy's eligible population, hurting sales momentum.Penmenvy approval and pipeline efforts may aid growth, but benefits will take time.GSK plc (GSK) is one of the key vaccine makers in the world, marketing vaccines to help prevent infectious diseases like Respiratory Syncytial Virus or RSV, meningitis, shingles, hepatitis and many more.GSK’s Vaccine sales are declining in th ...
How NYT's Digital Subscriptions Are Changing Revenue Dynamics
ZACKS· 2025-09-16 16:15
Key Takeaways NYT ended Q2 with 11.88M subscribers, including 11.3M digital-only and 6.02M bundle users.Q2 digital-only subscription revenues rose 15.1% to $350.4M, driving overall top-line growth.Management projects 13-16% Q3 digital-only subscription revenue growth, showing strong momentum.The New York Times Company (NYT) has embraced digital transformation with a clear focus on subscription-driven growth. As the media landscape shifts, NYT has made digital subscriptions the core of its strategy, using to ...
Football Season Could Massively Benefit This Stock
ZACKS· 2025-09-16 16:15
Key Takeaways DraftKings looks to benefit from the football craze. Increased interest in gaming and fantasy-related services provide a boost. DKNG broke multiple quarterly records in its latest release. As many are aware, football season is in full swing now, with many glued to their TVs on weekend afternoons. While the season kicking off is exciting for fans, several companies, including DraftKings (DKNG) , are also undoubtedly excited, with their gaming operations set to see a surge.Let’s take a closer lo ...
Nestlé Chairman Paul Bulcke decides to step down; Pablo Isla takes over as Chairman on October 1
Globenewswire· 2025-09-16 16:15
[Ad hoc announcement pursuant to Art. 53 LR] This press release is also available in Français (pdf) and Deutsch (pdf) ............. Vevey, 16 September 2025 Nestlé Chairman Paul Bulcke decides to step down; Pablo Isla takes over as Chairman on October 1 The Board of Directors of Nestlé S.A. has announced that Pablo Isla will become Chairman effective October 1, following Paul Bulcke's decision to step down from the Board earlier than planned. Paul Bulcke, Chairman of Nestlé, stated: "I have full trust in N ...